Sanofi takes another big hit as it halts work on breast cancer medication, amcenestrant
August 18, 2022 at 12:20 PM EDT
French healthcare company Sanofi has decided to halt work on its once praised breast cancer medication amcenestrant after a second failed clinical trial.
